Phage versus phagemid libraries for generation of human monoclonal antibodies.
about
Specific in vivo labeling of tyrosinated α-tubulin and measurement of microtubule dynamics using a GFP tagged, cytoplasmically expressed recombinant antibodyVirus outbreaks in chemical and biological sensorsFully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid AntibodiesHigh-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.On the influence of vector design on antibody phage displayCombinatorial approaches for the identification of brain drug delivery targets.Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection.The use of immunoliposome for nutrient target regulation (a review).Obligate multivalent recognition of cell surface tomoregulin following selection from a multivalent phage antibody library.Design of synthetic antibody libraries.Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.Design and testing of PCR primers for the construction of scFv libraries representing the immunoglobulin repertoire of rats.Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodiesAggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.Mining human antibody repertoires.Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigensIdentifying blood-brain-barrier selective single-chain antibody fragments.A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.Molecular considerations for development of phage antibody libraries.Discovery of internalizing antibodies to tumor antigens from phage libraries.Overview on the use of therapeutic antibodies in drug discovery.DeltaPhage--a novel helper phage for high-valence pIX phagemid display.Selection and characterization of cell binding and internalizing phage antibodies.Detection of biomarkers using recombinant antibodies coupled to nanostructured platformsAntibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining.High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy.Combining Phage and Yeast Cell Surface Antibody Display to Identify Novel Cell Type-Selective Internalizing Human Monoclonal AntibodiesN-Terminal labeling of filamentous phage to create cancer marker imaging agents.Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymomaM13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteinsMultivalent pIX phage display selects for distinct and improved antibody properties.Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.Identification of keratinocyte-specific markers using phage display and mass spectrometry.TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS.Molecular recognition in helix-loop-helix and helix-loop-helix-leucine zipper domains. Design of repertoires and selection of high affinity ligands for natural proteins.
P2860
Q27332419-3D9866D7-89E0-4753-ABAA-28FC1C17C0A0Q28395028-2B4D60E0-4256-4272-BA79-A6ABC8B67B42Q30372369-F4B793E9-BCA1-48BF-9573-AE6FEB3C15CCQ30605298-5A36702B-85E9-4E0C-8AAF-792161645021Q30826435-CA1A1AD6-FE70-4517-B032-5675F39328DFQ31119779-C6250733-9365-4F61-BA90-BD7B5A3E5317Q33257951-A7D6101E-7367-413F-9FEC-A283BF65EE70Q33263078-F00563A9-5483-46B7-8164-EF9AC541B905Q33263079-A8BFE6C9-EF2C-48DD-9AC4-C3295377A30DQ33283622-B29CE5E2-35EE-4536-BB10-DEB65FC5C2F5Q33289414-0477B7ED-C7C0-4181-A92D-59F0396BF1EAQ33317870-BBB8733E-0021-4A2D-A153-2BFBBA1FFD11Q33322420-EE9A35ED-8E6D-43B0-B5CF-F6904C4F0681Q33387145-40E34022-185F-4846-B3DA-25BA94748F5FQ33409529-283C609E-0A84-41A8-95AC-3F000322EC6FQ33566182-C1D1FA83-F15D-4594-988C-BF85EFF014D5Q33588489-AD128357-746D-41AF-AFDE-C67F5422840AQ33620053-41A7453D-5A6A-4376-B8CA-A73140DBA710Q33695432-116A44B8-248D-440A-BF3D-3DF86CA73AEFQ33816474-1E6B4D6A-009E-40B7-A2D7-9FA1AE7C501AQ33870905-0226FB05-96AF-4636-BD1D-1142AA27127DQ34032165-B2B6655E-B2F4-44A6-AE9D-0F5F51DC2464Q34114794-DF7922E8-750E-45B2-BDF5-9B5556BB0BC4Q34147273-1916ED14-7310-48EB-9BB7-D28225C7E60FQ34249101-77DBFF22-1EB3-4E47-B040-C79F233A64C8Q34280931-B69FCCC9-BD0A-4FAE-BDD1-6D08375766C8Q34352221-5B2F0DB0-A740-4FBC-A76A-0F6F1F0287C9Q34417503-A0627784-BC1F-4F94-AE68-928848CBD1CCQ34421055-77AB1BBD-9828-43E9-BDF7-83BF6C6240D8Q34560363-50310DFD-7CC6-4E03-9ED3-3877B2323846Q35419158-89864682-B6EF-4139-B3A4-D62562195DDEQ35659188-53E42A86-918F-4CD1-A676-018CAD406C5EQ36213754-3AA0819D-EAB7-4157-9686-52842A5A9207Q36214596-912A9B95-6B46-440C-8665-58B55C89FCCBQ36588148-30A80F00-AB53-4779-AB36-11A8E8B5B046Q37501464-226FC6DD-BA7A-4445-8C61-6C983CC25B80Q38020872-20DBECC8-3C0A-4C6C-9E0A-0A62D04DA497Q40663010-EC3CFC78-E9F4-4CAB-B39C-BE11F989DFF7Q42033562-28383840-0D6F-4422-BED0-ADFFC21A80DCQ44270152-0D07851A-8E44-4802-808D-9B1D7EA0BF0E
P2860
Phage versus phagemid libraries for generation of human monoclonal antibodies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@ast
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@en
type
label
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@ast
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@en
prefLabel
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@ast
Phage versus phagemid libraries for generation of human monoclonal antibodies.
@en
P2093
P1476
Phage versus phagemid libraries for generation of human monoclonal antibodies
@en
P2093
Arup Roy-Burman
Baltazar Becerril
David O'Connell
James D Marks
P356
10.1016/S0022-2836(02)00561-2
P407
P577
2002-08-01T00:00:00Z